Patent details

Basic Information

Publication number:

EP3236262

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP171590391

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

SURROGATE FUNCTIONAL DIAGNOSTICS TEST FOR CANCER

French Title of Invention:

ESSAI DE DIAGNOSTIC FONCTIONNEL DE SUBSTITUT POUR LE CANCER

German Title of Invention:

SURROGATFUNKTIONSDIAGNOSETEST FÜR KREBS

SPC Number:

Dates

Filing date:

10/05/2013

Grant date:

25/09/2019

EP Publication Date:

25/10/2017

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

25/09/2019

EP B1 Publication Date:

25/09/2019

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

10/05/2020

Expiration date:

10/05/2033

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

18/09/2019

 

 

Name:

Eutropics Pharmaceuticals, Inc.

Address:

767-C Concord Avenue, Cambridge, Massachusetts 02138, United States (US)

Inventor

1

Name:

CARDONE, Michael H.

Address:

United States (US)

2

Name:

PIERCEALL, William

Address:

United States (US)

Priority

1

Priority Number:

201261645253 P

Priority Date:

10/05/2012

Priority Country:

United States (US)

2

Priority Number:

201361780252 P

Priority Date:

13/03/2013

Priority Country:

United States (US)

Classification

IPC classification:

G01N 33/574;

Publication

European Patent Bulletin

Issue number:

201939

Publication date:

25/09/2019

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages